Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gervain

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Orvosi Hetilap|January 23, 1999
[What are the costs of the diagnosis and therapy of hepatitis B in a single patient in Hungary today?]G Simon, J Gervain, A Gógl
Orvosi Hetilap|April 16, 1995
[Benign recurrent intrahepatic cholestasis]J Gervain, A Gógl, I Kádas
Scandinavian Journal of Gastroenterology. Supplement|December 29, 1998
Hepatitis C virus infection: pathogenesis, diagnosis and treatmentA Pár, J Gervain, A Gógl
Orvosi Hetilap|March 9, 1997
[How great is the risk of personal contact in the transmission of hepatitis C virus infection?]J Gervain, A Gógl, G Szabó, et al.
Orvosi Hetilap|August 8, 2001
[Determination of the type and subtype of the hepatitis C virus in chronic viral hepatitis patients in Hungary]J Gervain, G Simon, I Papp, et al.
Orvosi Hetilap|January 1, 1995
[Clinical immunological features and interferon therapy in chronic hepatitis C]A Pár, M Paál, A Gógl, et al.
Orvosi Hetilap|June 2, 1996
[Effect of interferon-alpha2b therapy in chronic hepatitis C]J Fehér, G Lengyel, L Dalmi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 14, 2015
Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across EuropeR Ozaras, G Corti, S Ruta, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Orvosi Hetilap|January 23, 1999
[What are the costs of the diagnosis and therapy of hepatitis B in a single patient in Hungary today?]G Simon, J Gervain, A Gógl
Orvosi Hetilap|April 16, 1995
[Benign recurrent intrahepatic cholestasis]J Gervain, A Gógl, I Kádas
Scandinavian Journal of Gastroenterology. Supplement|December 29, 1998
Hepatitis C virus infection: pathogenesis, diagnosis and treatmentA Pár, J Gervain, A Gógl
Orvosi Hetilap|March 9, 1997
[How great is the risk of personal contact in the transmission of hepatitis C virus infection?]J Gervain, A Gógl, G Szabó, et al.
Orvosi Hetilap|August 8, 2001
[Determination of the type and subtype of the hepatitis C virus in chronic viral hepatitis patients in Hungary]J Gervain, G Simon, I Papp, et al.
Orvosi Hetilap|January 1, 1995
[Clinical immunological features and interferon therapy in chronic hepatitis C]A Pár, M Paál, A Gógl, et al.
Orvosi Hetilap|June 2, 1996
[Effect of interferon-alpha2b therapy in chronic hepatitis C]J Fehér, G Lengyel, L Dalmi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 14, 2015
Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across EuropeR Ozaras, G Corti, S Ruta, et al.
Pageof 1